Relafen 750, pharmacologically known as naproxen, showcases a fascinating illustration within the molecular pharmacy domain . Its mode of function copyrights on inhibiting cyclooxygenase proteins, specifically COX-1 and COX-2, thereby decreasing the generation of prostaglandins, which are essential mediators of inflammation and fever . This specifi